Mental and Behavioral Disorders Due to the Use of Hallucinogens

What are Mental and Behavioral Disorders Due to the Use of Hallucinogens?

It develops thanks to the psychedelic movement in modern culture.

Causes of Mental and Behavioral Disorders Due to the Use of Hallucinogens

The group includes the use of psychotomimetics such as LSD, mescaline, psilocybin, as well as phencyclidine and Ecstasy (3,4-methylenedioxymethamphetamine), which have both hallucinogenic and amphetamine effects. Used per os, as applications on the mucous membranes, in cigarettes.

Symptoms of Mental and Behavioral Disorders Due to the Use of Hallucinogens

Acute intoxication

Uncontrolled laughter, crying, mood changes, formal disturbances in thinking, euphoria, synesthesia, depersonalization and derealization. Phencyclidine intoxication resembles amphetamine.

Harmful use

Somatic symptoms include tachycardia, increased blood pressure, mydriasis, sweating, fever, nausea, dizziness, and psychopathological symptoms include mental dullness and depression.

Addiction syndrome

Mostly mental addiction.

Withdrawal syndrome

Mood change. There is no pronounced withdrawal syndrome.

Psychotic disorder

Schizophrenia-like disorder with symptoms of depersonalization and derealization, panic attacks, distorted perception of time, visual and auditory pseudo-and true hallucinations, stereotyped repetition of visual images, ideas of exposure. Delusions of attitude, meaning and harassment.

Amnestic syndrome

Not very pronounced.

Residual wealth and psychotic disorder with delayed debut

Mental dullness and the re-emergence of visual or depersonalization images.

Diagnosis of Mental and Behavioral Disorders Due to the Use of Hallucinogens

Based on the history and description of the clinic of intoxication.

Differential diagnosis

Differentiate with schizophrenia, schizoaffective disorder and alcohol delirium, organic narcolepsy based on follow-up observation, history data.

Treating Mental and Behavioral Disorders Due to the Use of Hallucinogens

Prescription of benzodiazepines and barbiturates, detoxification and increased excretion of psychoactive substances.